Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMPEDIMED LIMITED Share Issue/Capital Change 2016

Jan 24, 2016

65135_rns_2016-01-24_1ec01d1d-bc49-4935-b309-fbe0372c9612.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix
3B New
issue
announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

ImpediMed Limited (the “Company”)

ABN

65 089 705 144

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

  • 1 +Class of +securities issued or Options (unquoted), under the Employee to be issued Incentive Plan that was approved by shareholders at the 2014 Annual General Meeting (Options).

  • 2 Number of[[+]] securities issued or to be issued (if known) or maximum number which may be issued

  • 2 Number of[[+]] securities issued or 350,000 Options to be issued (if known) or maximum number which may be issued

  • 3 Principal terms of the Issue of 350,000 Options with an exercise +securities (e.g. if options, price of $1.05. Of these, 87,500 vest on 18 exercise price and expiry date; January 2017. The remaining options vest if partly paid[+] securities, the evenly on a monthly basis over the next

  • amount outstanding and due three years, with an expiry date for all

  • dates for payment; if +convertible securities, the Options of 18 January 2023. conversion price and dates for conversion)

Appendix
3B New
issue
announcement

  • 4 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted[+] securities? If the additional[+] securities do not rank equally, please state:

  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

No.

The Options and Performance Rights do not carry a right to participate in dividends or interest payments. Fully paid ordinary shares (ranking equally in all respects with existing fully paid ordinary shares) will be issued upon the exercise of Options.

5 Issue price or consideration Nil consideration 6 Purpose of the issue Grants, under the Employee Incentive Plan (If issued as consideration for and the US Sub-Plan, which were the acquisition of assets, clearly approved by shareholders at the 2014 identify those assets) Annual General Meeting. 6a Is the entity an[+] eligible entity No. that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder Not applicable resolution under rule 7.1A was passed 6c Number of[+] securities issued Not applicable without security holder approval under rule 7.1 6d Number of[+] securities issued Not applicable with security holder approval under rule 7.1A

Appendix
3B New
issue
announcement

6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific
security
holder
approval
(specify
date
of
meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least
75% of 15 day VWAP as
calculated under rule 7.1A.3?
Include the+issue date and
both values. Include the source
of the VWAP calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which valuation of consideration
was released to ASX Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1
and rule 7.1A – complete
Annexure 1 and release to ASX
Market Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for
a pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)
9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
Not applicable Not applicable
Not applicable

Not applicable
Not applicable
Not applicable
20 January 2016
Number +Class
293,752,367 Ordinary shares
Number +Class
29,124,358 (after
350,000 granted
and 206,828
expired)
2,760,000
Options
Performance Rights

Appendix
3B New
issue
announcement

  • 10 Dividend policy (in the case of a Not applicable trust, distribution policy) on the increased capital (interests)

Part 2 - Pro rata issue

11
Is
security
holder
approval
required?
12
Is the issue renounceable or
non-renounceable?
13
Ratio in which the+securities will
be offered
14
+Class of+securities to which
the offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements
in relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the
issue
23
Fee or commission payable to
the broker to the issue
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable

Appendix
3B New
issue
announcement

24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date
entitlement
and
acceptance
form
and
offer
documents
will
be
sent
to
persons entitled
27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell
their entitlements_in full_through
a broker?
31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable